CIK 0000025743
- Non-accelerated filer
- Smaller reporting company
TherapeuticsMD, Inc.
Sign in to watch- Ticker
- TXMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 870233535
- Phone
- +1 561-961-1900
- Business address
- 951 YAMATO ROAD, SUITE 220, BOCA RATON, FL, 33431
- Former names
- AMHN, Inc., CROFF ENTERPRISES INC, CROFF OIL CO
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 64 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-05-12 | Milligan John C.K. IV President/Secretary | Exercise or conversion | +20,000 | $0.10 | $2K | 1,742,419 |
| 2014-05-12 | Milligan John C.K. IV President/Secretary | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −20,000 | 2,032,255 | ||
| 2014-05-09 | LaPenta Robert V Jr Director | Purchase | +2,000 | $3.58 | $7K | 7,000 |
| 2014-05-09 | LaPenta Robert V Jr Director | Purchase | +3,000 | $3.72 | $11K | 10,000 |
| 2014-05-09 | Finizio Robert G CEO | Exercise or conversion | +31,526 | $3.00 | $95K | 21,061,059 |
| 2014-05-09 | Finizio Robert G CEO | Exercise or conversion · Non-qualified Stock Option (right to buy) | +31,526 | 268,474 | ||
| 2014-05-08 | Thompson Tommy G Director | Purchase | +14,000 | $3.57 | $50K | 644,000 |
| 2014-03-26 | Finizio Robert G CEO | Sale | −982,053 | $6.70 | $6.6M | 21,029,533 |
| 2014-03-26 | Milligan John C.K. IV President/Secretary | Sale | −353,412 | $6.70 | $2.4M | 3,892,187 |
| 2014-03-26 | SEGAL NICHOLAS Director | Sale | −30,000 | $6.70 | $201K | 215,485 |
| 2014-03-26 | SEGAL NICHOLAS Director | Sale | −185,298 | $6.70 | $1.2M | 225,809 |
| 2014-03-26 | Bernick Brian Director | Sale | −421,268 | $6.70 | $2.8M | 6,735,999 |
| 2014-03-10 | Krassan Mitchell EVP, Chief Strategy Officer | Exercise or conversion | +7,500 | $0.19 | $1K | 7,500 |
| 2014-03-10 | Krassan Mitchell EVP, Chief Strategy Officer | Sale | −7,500 | $7.73 | $58K | 0 |
| 2014-03-10 | Krassan Mitchell EVP, Chief Strategy Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −7,500 | 143,203 | ||
| 2014-03-07 | Bernick Brian Director | Sale | −1,626,703.64 | 7,157,267 | ||
| 2014-03-07 | Bernick Brian Director | Sale · Stock Option (right to buy) | −334,762.98 | 1,472,910 | ||
| 2014-03-07 | Bernick Brian Director | Sale · Warrant (right to buy) | −13,948.63 | 61,372 | ||
| 2014-03-07 | Bernick Brian Director | Sale · Stock Option (right to buy) | −11,364 | 50,000 | ||
| 2014-03-07 | Bernick Brian Director | Sale · Stock Option (right to buy) | −34,092 | 150,000 |
Page 28 of 33 · 642 trades